Logo Logo Logo Logo Logo
  • HOME
  • ABOUT
    • Management
    • Board of Directors
  • ADDICTION
    • Alcohol Addiction
    • Limitations of Current AUD Therapies
    • Our Proposed Solution
  • TECHNOLOGY
    • Overview
    • Phase 2b Clinical Trial Results
    • History of Ondansetron Use for AUD
    • Strengths and Competitive Advantages
  • Newsroom
    • Press Releases
    • Media
  • INVESTORS
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • CONTACT
  • HOME
  • ABOUT
    • Management
    • Board of Directors
  • ADDICTION
    • Alcohol Addiction
    • Limitations of Current AUD Therapies
    • Our Proposed Solution
  • TECHNOLOGY
    • Overview
    • Phase 2b Clinical Trial Results
    • History of Ondansetron Use for AUD
    • Strengths and Competitive Advantages
  • INVESTORS
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • CONTACT

Press Releases

Investor Relations

Investor Relations

  • Overview
  • Analyst Coverage
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance

Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices

Oct 22, 2020

Adial Pharmaceuticals Announces FDA Reactivation of its Investigational New Drug Application for AD04 in Alcohol Use Disorder

Oct 21, 2020

Adial Pharmaceuticals Announces Sale of 10,000 COVID-19 Antibody Rapid Test Devices

Sep 30, 2020

Adial Pharmaceuticals Announces COVID-19 Point-of-Care Antibody Test Granted First Ever FDA Emergency Use Authorization for Use with Fingerstick Blood Samples

Sep 29, 2020

Adial Pharmaceuticals Files for Expedited Review of AD04 with the FDA

Sep 25, 2020

Adial Pharmaceuticals and iRemedy Partner to Sell COVID-19 Antibody Test Kits to U.S. Medical Providers and Commence Sales

Sep 22, 2020

Adial Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 16th

Sep 9, 2020

Adial Pharmaceuticals to Present at The LD Micro 500 Virtual Conference on September 2nd

Sep 1, 2020

Adial Pharmaceuticals Announces Third-Party Sales and Distribution Agreement with Brik for Rapid Result COVID-19 Antibody Test Kits

Aug 6, 2020

Adial Pharmaceuticals Schedules Business and Clinical Update Conference Call

Jul 28, 2020
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...11

    ©Adial Pharmaceuticals 2021